Collectively, these results demonstrate that NKG2D has a substantial effect on tumorigenesis, accelerating the progression of hepatocellular carcinoma in DEN-treated mice, without altering the type of tumours that ultimately develop. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.